# Absorb GT1 Japan PMS

Study · id `cardio:ct-nct03409731` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03409731](<https://clinicaltrials.gov/study/NCT03409731>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03409731

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 135 participants.

## Technical summary

Registry record NCT03409731. Allocation not applicable; no masking; primary purpose prevention. Start 2016-12-13 (actual); primary completion 2023-02-06 (actual). Results posted on 2019-01-03.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 135 participants (enrolled count; ClinicalTrials.gov record NCT03409731, source copy `cardio:ctgov-nct03409731-2024-08-06`, retrieved 2026-10-26)
- Started: 2016-12-13 (actual) (ClinicalTrials.gov record NCT03409731, source copy `cardio:ctgov-nct03409731-2024-08-06`, retrieved 2026-10-26)
- Primary completion: 2023-02-06 (actual) (ClinicalTrials.gov record NCT03409731, source copy `cardio:ctgov-nct03409731-2024-08-06`, retrieved 2026-10-26)
- Completion: 2023-02-06 (actual) (ClinicalTrials.gov record NCT03409731, source copy `cardio:ctgov-nct03409731-2024-08-06`, retrieved 2026-10-26)
- Results first posted: 2019-01-03 (ClinicalTrials.gov record NCT03409731, source copy `cardio:ctgov-nct03409731-2024-08-06`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT03409731, source copy `cardio:ctgov-nct03409731-2024-08-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03409731-2024-08-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Absorb GT1 Japan PMS
- Condition: Ischemic Heart Disease
- Condition: Angina Pectoris
- Condition: Coronary Artery Disease
- Condition: Coronary Artery Occlusion
- Condition: Myocardial Ischemia
- Intervention (Device): ABSORB GT1 BVS
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: f634dc07e1e2dbc2106e65da0a69cc8ac89a6035e2cdfefc9cb429388b295511
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
